A.N. Plotnikov

Weizmann Institute of Science — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

45h-index9.7kcitations177works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(23), Epigenetics and DNA Methylation(21), Histone Deacetylase Inhibitors Research(19), Cancer-related gene regulation(17), Fibroblast Growth Factor Research(16)

Publications177 total

Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia
Hypertension·2025· 3 cited
Economics and organization of investment in construction
2025
Inhibitors of eIF1A-ribosome interaction unveil uORF-dependent regulation of translation initiation and antitumor and antiviral effects
The EMBO Journal·2025Open Access
Abstract LB457: Suppressing liver metastasis growth by inducing the endogenous expression of the tumor suppressor miR-34a by small synthetic molecules
Cancer Research·2025
Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
eLife·2024· 5 citedOpen Access
Author response: Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
2024Open Access
Reviewer #2 (Public Review): Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
2024Open Access
Author response: Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
2024Open Access
Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
2024Open Access
Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
eLife·2024· 4 citedOpen Access
Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
2024Open Access
Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure
iScience·2024· 5 citedOpen Access
Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas
2024Open Access
Data from Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3β Impairs Degradation of Prolactin Receptor
2023Open Access
Supplementary Figures 1-10, Procedures from Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3β Impairs Degradation of Prolactin Receptor
2023Open Access
Supplementary Figures 1-10, Procedures from Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3β Impairs Degradation of Prolactin Receptor
2023Open Access
Data from Oncogene-Mediated Inhibition of Glycogen Synthase Kinase 3β Impairs Degradation of Prolactin Receptor
2023Open Access
Correction: A duplex structure of SARM1 octamers stabilized by a new inhibitor
Cellular and Molecular Life Sciences·2023· 1 citedOpen Access
RKI-1447, a ROCK Inhibitor, Targets SRSF2 Mutated Leukemia by Disrupting Cell Mitosis and Nuclear Morphology
SSRN Electronic Journal·2023Open Access
A duplex structure of SARM1 octamers stabilized by a new inhibitor
Cellular and Molecular Life Sciences·2022· 12 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Ming‐Ming Zhou(10), P. Loppnau(9), Moosa Mohammadi(8), Lei Zeng(8), Rony Seger(7), Hong Wu(7), Jinrong Min(7), Abdellah Allali‐Hassani(7), Anna V. Eliseenkova(6), Masoud Vedadi(6), Alexey Bochkarev(6), Hong Zeng(5), C.H. Arrowsmith(5), A. Schuetz(5), Aiping Dong(5), E. V. Rusinova(5), Haim Barr(4), Fernando A. Martín(4), Jennifer Joshua(4), Serge Y. Fuchs(4)